Kristen K Buono, MD
Undefined Physician Type (Specify) · Fontana
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 13 years
- University of California, San Diego School of Medicine, 2013
Offices
2 locations · Southern California Permanente Medical Group · 11,250 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Buono’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A131712 · Current
Licensed to practise in California · since 2014 · expires 2028-04-30 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$139,385
Medicare paid this office $139,385 for 420 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dilation of urethra using an endoscope | 47 | $12,955 | $276 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 40 | $12,217 | $305 |
| Short return visit (20+ min) | 220 | $11,996 | $49 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 39 | $11,222 | $288 |
| Botox | 16 | $8,430 | None |
See all 20 services
| Dilation of urethra using an endoscope | 47 | $12,955 | $276 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 40 | $12,217 | $305 |
| Short return visit (20+ min) | 220 | $11,996 | $49 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 39 | $11,222 | $288 |
| Botox | 16 | $8,430 | None |
| Insertion of device into abdomen with pressure and urine flow rate study | 50 | $8,312 | $166 |
| New patient visit (45+ min) | 80 | $8,143 | $102 |
| Return visit (30+ min) | 90 | $7,783 | $80 |
| Insertion of lower leg neurostimulator electrode | 17 | $5,788 | $88 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 16 | $4,998 | $312 |
| Repair of bulging of rectum and bladder into vaginal wall | 11 | $4,704 | $428 |
| Fitting and insertion of vaginal support device | 42 | $4,264 | $49 |
| Insertion of temporary bladder tube | 114 | $3,751 | $30 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 11 | $3,678 | $334 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 58 | $2,440 | $27 |
| Long return visit (40+ min) | 12 | $1,350 | $113 |
| Urinalysis, manual test | 154 | $849 | $3 |
| Short return visit | 21 | $598 | $25 |
| Pessary, reusable, non rubber, any type | 15 | $567 | $33 |
| Electronic assessment of bladder emptying | 59 | $547 | $6 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Electronic assessment of bladder emptying | 31 | 266 | 491 | 281 | 91 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | – | 275 | 490 | 277 | 90 |
| Insertion of temporary bladder tube | 18 | 208 | 359 | 330 | 124 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | – | 107 | 217 | 124 | 39 |
| Fitting and insertion of vaginal support device | – | 61 | 142 | 171 | 87 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | – | 95 | 210 | 113 | 40 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
420 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 13% · Women 100% · Also on Medicaid 13% · Health risk score 1.10. At or below the middle of the specialty; the typical undefined physician type clinician is at 1.67.
Conditions among them: High blood pressure 69% · Depression 27% · Diabetes 24% · Chronic kidney disease 22% · Coronary heart disease 20% · Cancer 15% · COPD 14% · Atrial fibrillation 14% · Heart failure 12% · Stroke 7% · Dementia 4%.
The office billed $428,122, Medicare allowed $194,021 and paid $139,385; for 3,221 services of 51 kinds; $14,246 of it was for drugs given in the office and $125,138 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 420 | 3,221 | 76 | 1.10 | $428,122 | $139,385 |
| 2023 | 785 | 11,933 | 75 | 0.97 | $1,261,243 | $437,370 |
| 2022 | 723 | 9,986 | 75 | 0.99 | $1,198,538 | $391,303 |
| 2021 | 382 | 4,218 | 75 | 0.93 | $663,044 | $216,899 |
| 2020 | 79 | 325 | 72 | 0.94 | $96,733 | $22,494 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 28 services
| Short return visit (20+ min) | 522 | $46,563 | $60 |
| Botox | 44 | $37,803 | None |
| Dilation of urethra using an endoscope | 125 | $35,396 | $281 |
| Return visit (30+ min) | 238 | $30,116 | $92 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 92 | $27,237 | $220 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 83 | $25,319 | $224 |
| New patient visit (45+ min) | 193 | $23,659 | $123 |
| Repair of bulging of rectum and bladder into vaginal wall | 38 | $23,232 | $611 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 46 | $21,940 | $338 |
| Insertion of device into abdomen with pressure and urine flow rate study | 84 | $14,521 | $151 |
| Insertion of sacral nerve neurostimulator electrode array | 13 | $12,000 | $923 |
| Insertion of temporary bladder tube | 304 | $11,937 | $36 |
| Creation of sling around urethra in female to control leakage | 27 | $11,681 | $433 |
| Insertion of lower leg neurostimulator electrode | 38 | $11,203 | $97 |
| Fitting and insertion of vaginal support device | 80 | $9,939 | $58 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 29 | $9,286 | $244 |
| Removal of uterus through vagina, 250.0 g or less | 16 | $5,956 | $372 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 126 | $5,664 | $20 |
| Long return visit (40+ min) | 41 | $5,504 | $125 |
| Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies | 11 | $5,302 | $204 |
| New patient visit (60+ min) | 30 | $5,280 | $176 |
| Repair of prolapsing vaginal vault through vagina | 15 | $4,528 | $302 |
| Injection of implant material beneath lining of bladder and/or urethra using an endoscope | 11 | $4,095 | $315 |
| Simple bladder irrigation and/or instillation | 13 | $2,693 | $56 |
| Short return visit | 51 | $2,659 | $35 |
| Urinalysis, manual test | 371 | $2,389 | $3 |
| Electronic assessment of bladder emptying | 130 | $1,274 | $5 |
| Pessary, reusable, non rubber, any type | 27 | $1,253 | $37 |
2022: 24 services
| Short return visit (20+ min) | 386 | $36,666 | $63 |
| Dilation of urethra using an endoscope | 121 | $34,558 | $286 |
| Return visit (30+ min) | 213 | $31,759 | $96 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 109 | $30,223 | $139 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 105 | $29,152 | $139 |
| Botox | 29 | $23,837 | None |
| Insertion of lower leg neurostimulator electrode | 55 | $20,532 | $102 |
| New patient visit (45+ min) | 157 | $19,878 | $127 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 29 | $13,819 | $345 |
| Insertion of temporary bladder tube | 320 | $13,228 | $37 |
| Creation of sling around urethra in female to control leakage | 30 | $13,146 | $438 |
| New patient visit (60+ min) | 83 | $12,898 | $155 |
| Repair of bulging of rectum and bladder into vaginal wall | 22 | $12,450 | $566 |
| Long return visit (40+ min) | 48 | $9,116 | $140 |
| Short return visit | 146 | $8,749 | $37 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 30 | $8,008 | $133 |
| Fitting and insertion of vaginal support device | 76 | $7,925 | $56 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 146 | $6,819 | $14 |
| Insertion of device into abdomen with pressure and urine flow rate study | 34 | $5,846 | $86 |
| Repair of prolapsing vaginal vault through vagina | 11 | $3,253 | $296 |
| Urinalysis, manual test | 368 | $2,648 | $3 |
| Simple bladder irrigation and/or instillation | 30 | $1,618 | $37 |
| Electronic assessment of bladder emptying | 152 | $1,500 | $3 |
| Pessary, reusable, non rubber, any type | 26 | $1,069 | $37 |
2021: 23 services
| Dilation of urethra using an endoscope | 85 | $24,806 | $285 |
| Return visit (30+ min) | 143 | $20,950 | $94 |
| New patient visit (45+ min) | 136 | $17,603 | $129 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure studies | 54 | $14,896 | $139 |
| Short return visit (20+ min) | 157 | $14,005 | $70 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 48 | $13,416 | $141 |
| Long return visit (40+ min) | 47 | $10,367 | $140 |
| Insertion of temporary bladder tube | 195 | $7,905 | $38 |
| Insertion of lower leg neurostimulator electrode | 26 | $7,833 | $112 |
| Creation of sling around urethra in female to control leakage | 20 | $7,489 | $374 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 26 | $7,376 | $145 |
| Insertion of sacral nerve neurostimulator electrode | 12 | $6,613 | $551 |
| Repair of bulging of rectum and bladder into vaginal wall | 15 | $6,610 | $441 |
| Short return visit | 71 | $4,144 | $43 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 88 | $3,991 | $15 |
| Fitting and insertion of vaginal support device | 47 | $3,534 | $58 |
| New patient visit (60+ min) | 20 | $3,401 | $170 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 12 | $1,562 | $130 |
| Urinalysis, manual test | 213 | $1,509 | $3 |
| Pessary, reusable, non rubber, any type | 21 | $908 | $43 |
| Electronic assessment of bladder emptying | 90 | $815 | $3 |
| Simple bladder irrigation and/or instillation | 13 | $721 | $42 |
| Imaging guidance for procedure, 60 minutes or less | 12 | $154 | $13 |
2020: 8 services
| New patient visit (45+ min) | 22 | $2,932 | $133 |
| Creation of sling around urethra in female to control leakage | 24 | $1,725 | $72 |
| Repair of bulging of rectum and bladder into vaginal wall | 20 | $1,629 | $81 |
| Short return visit (20+ min) | 11 | $903 | $53 |
| Insertion of temporary bladder tube | 18 | $626 | $35 |
| Repair of pelvic ligaments through vagina | 12 | $434 | $36 |
| Electronic assessment of bladder emptying | 11 | $201 | $6 |
| Urinalysis, manual test | 24 | $144 | $3 |
Medicaid work
$1,707 in 2024
Medicaid paid $1,707 for 242 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 18 | $586 |
| Short return visit (20+ min) | 63 | $410 |
| Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine) | 21 | $256 |
| Return visit (30+ min) | 12 | $225 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $172 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 79 | $58 |
| TOBACCO NON-USER | 37 | $0 |
| 2024 | 242 | 7 | 28 | $1,707 |
| 2023 | 389 | 4 | 25 | $939 |
| 2022 | 782 | 7 | 26 | $1,892 |
| 2021 | 368 | 6 | 24 | $36 |
| 2020 | 24 | 1 | 13 | $0 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 179 | $824 |
| Return visit (30+ min) | 14 | $75 |
| Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine) | 28 | $29 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 168 | $12 |
2022
| Return visit (30+ min) | 100 | $808 |
| Short return visit (20+ min) | 170 | $774 |
| Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine) | 89 | $134 |
| CYSTOSCOPY AND TREATMENT | 12 | $127 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 58 | $27 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 297 | $12 |
| ANAL/URINARY MUSCLE STUDY | 56 | $10 |
2021
| Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine) | 25 | $29 |
| Short return visit (20+ min) | 29 | $7 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 41 | $0 |
| ANAL/URINARY MUSCLE STUDY | 40 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 195 | $0 |
| Return visit (30+ min) | 38 | $0 |
2020
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 24 | $0 |
Drugs they prescribed that Part D paid
$232,906
Pharmacies billed $232,906 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (33 of 862) in 2024. Above the middle of the specialty; the typical undefined physician type clinician is at 0%.
574 generic and 288 brand-name prescriptions · $232,906 in drug cost · 232 antibiotic prescriptions to 146 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 118 | $103,406 | $876 |
| Myrbetriq | 104 | $81,329 | $782 |
| Estradiol | 212 | $14,182 | $67 |
| Premarin | 12 | $5,155 | $430 |
| Mirabegron Er | 13 | $5,038 | $388 |
See all 15 drugs
| Gemtesa | 118 | $103,406 | $876 |
| Myrbetriq | 104 | $81,329 | $782 |
| Estradiol | 212 | $14,182 | $67 |
| Premarin | 12 | $5,155 | $430 |
| Mirabegron Er | 13 | $5,038 | $388 |
| Nitrofurantoin Mono-Macro | 84 | $2,179 | $26 |
| Trospium Chloride | 23 | $2,138 | $93 |
| Trimethoprim | 19 | $1,154 | $61 |
| Clobetasol Propionate | 12 | $622 | $52 |
| Cephalexin | 45 | $366 | $8 |
| Ibuprofen | 34 | $334 | $10 |
| Progesterone | 11 | $227 | $21 |
| Sulfamethoxazole-Trimethoprim | 50 | $210 | $4 |
| Ondansetron Odt | 12 | $95 | $8 |
| Oxycodone | 25 | $77 | $3 |
Year by year
| 2024 | 862 | 353 | 4% (33) | 33% | $232,906 |
| 2023 | 1,201 | 425 | 6% (73) | 32% | $321,240 |
| 2022 | 870 | 306 | 6% (54) | 34% | $230,352 |
| 2021 | 612 | 215 | 3% (18) | 32% | $133,058 |
| 2020 | 384 | 170 | None | 42% | $84,458 |
| 2019 | 444 | 208 | 3% (11) | 43% | $94,358 |
| 2018 | 449 | 199 | 4% (16) | 47% | $100,762 |
| 2017 | 203 | 113 | 8% (17) | 34% | $25,379 |
| 2016 | 15 | 11 | None | None | $1,050 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Myrbetriq | 167 | $163,439 | $979 |
| Gemtesa | 101 | $97,867 | $969 |
| Estradiol | 244 | $26,137 | $107 |
| Premarin | 23 | $10,205 | $444 |
| Estring | 11 | $6,219 | $565 |
| Nitrofurantoin Mono-Macro | 158 | $3,169 | $20 |
| Nitrofurantoin | 29 | $1,460 | $50 |
| Ibuprofen | 71 | $872 | $12 |
| Sulfamethoxazole-Trimethoprim | 137 | $617 | $5 |
| Cephalexin | 74 | $490 | $7 |
| Ondansetron Odt | 13 | $182 | $14 |
| Oxycodone | 52 | $101 | $2 |
| Hydrocodone-Acetaminophen | 15 | $92 | $6 |
| Amoxicillin-Clavulanate Potass | 13 | $90 | $7 |
| Fluconazole | 11 | $38 | $3 |
2022: 13 drugs
| Myrbetriq | 145 | $152,723 | $1,053 |
| Gemtesa | 25 | $26,154 | $1,046 |
| Estradiol | 167 | $20,076 | $120 |
| Premarin | 15 | $6,327 | $422 |
| Estring | 12 | $6,156 | $513 |
| Nitrofurantoin Mono-Macro | 117 | $2,040 | $17 |
| Trimethoprim | 20 | $1,162 | $58 |
| Nitrofurantoin | 12 | $1,091 | $91 |
| Ibuprofen | 52 | $718 | $14 |
| Clobetasol Propionate | 16 | $535 | $33 |
| Cephalexin | 54 | $423 | $8 |
| Sulfamethoxazole-Trimethoprim | 88 | $238 | $3 |
| Oxycodone | 40 | $87 | $2 |
2021: 15 drugs
| Myrbetriq | 91 | $84,816 | $932 |
| Estradiol | 77 | $10,107 | $131 |
| Estring | 17 | $8,683 | $511 |
| Premarin | 17 | $7,036 | $414 |
| Toviaz | 13 | $5,679 | $437 |
| Trospium Chloride | 20 | $1,608 | $80 |
| Nitrofurantoin Mono-Macro | 82 | $1,312 | $16 |
| Nitrofurantoin | 15 | $658 | $44 |
| Cephalexin | 56 | $384 | $7 |
| Trimethoprim | 20 | $381 | $19 |
| Ibuprofen | 26 | $284 | $11 |
| Sulfamethoxazole-Trimethoprim | 49 | $206 | $4 |
| Amitriptyline | 13 | $120 | $9 |
| Ciprofloxacin | 12 | $84 | $7 |
| Oxycodone | 13 | $19 | $1 |
2020: 12 drugs
| Myrbetriq | 47 | $33,691 | $717 |
| Estring | 36 | $17,186 | $477 |
| Estradiol | 54 | $7,110 | $132 |
| Monurol | 16 | $6,265 | $392 |
| Premarin | 14 | $5,954 | $425 |
| Methenamine Hippurate | 11 | $3,186 | $290 |
| Nitrofurantoin Mono-Macro | 47 | $1,544 | $33 |
| Estradiol (Twice Weekly) | 11 | $794 | $72 |
| Trimethoprim | 20 | $236 | $12 |
| Cephalexin | 22 | $172 | $8 |
| Ibuprofen | 13 | $113 | $9 |
| Sulfamethoxazole-Trimethoprim | 28 | $96 | $3 |
2019: 13 drugs
| Myrbetriq | 75 | $46,167 | $616 |
| Estring | 35 | $17,495 | $500 |
| Estrace | 30 | $7,697 | $257 |
| Estradiol | 58 | $6,021 | $104 |
| Monurol | 22 | $5,778 | $263 |
| Methenamine Hippurate | 21 | $4,468 | $213 |
| Trospium Chloride | 14 | $1,081 | $77 |
| Nitrofurantoin Mono-Macro | 29 | $639 | $22 |
| Trimethoprim | 14 | $267 | $19 |
| Sulfamethoxazole-Trimethoprim | 37 | $187 | $5 |
| Cephalexin | 25 | $183 | $7 |
| Ibuprofen | 12 | $160 | $13 |
| Oxycodone | 11 | $51 | $5 |
2018: 11 drugs
| Myrbetriq | 74 | $39,106 | $528 |
| Estring | 30 | $13,431 | $448 |
| Estrace | 66 | $9,724 | $147 |
| Monurol | 21 | $6,584 | $314 |
| Estradiol | 34 | $5,591 | $164 |
| Trospium Chloride | 16 | $2,124 | $133 |
| Nitrofurantoin Mono-Macro | 30 | $750 | $25 |
| Trimethoprim | 28 | $712 | $25 |
| Sulfamethoxazole-Trimethoprim | 32 | $159 | $5 |
| Oxycodone | 12 | $125 | $10 |
| Cephalexin | 14 | $124 | $9 |
2017: 4 drugs
| Myrbetriq | 14 | $7,611 | $544 |
| Estrace | 12 | $3,326 | $277 |
| Nitrofurantoin Mono-Macro | 33 | $569 | $17 |
| Sulfamethoxazole-Trimethoprim | 28 | $114 | $4 |
Money from drug and device companies
$177 in 2024
| 2024 | 4 | 7 | None | $177 |
| 2023 | 7 | 31 | None | $1,005 |
| 2022 | 7 | 43 | None | $1,960 |
| 2021 | 9 | 48 | $473 | $1,449 |
| 2020 | 5 | 8 | None | $190 |
| 2019 | 2 | 3 | None | $91 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Myrbetriq | $73 | 3 payments
|
| Axonics | Axonics | $66 | 2 payments
|
| Abbvie | Botox | $23 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $16 | 1 payment
|
See all 7 published payments
| Astellas Pharma US | Meals · 2024-09-14 | Veozah | $29 |
| Astellas Pharma US | Meals · 2024-04-22 | Myrbetriq | $25 |
| Sumitomo Pharma America | Meals · 2024-04-18 | Gemtesa | $16 |
| Axonics | Meals · 2024-04-10 | Axonics | $36 |
| Abbvie | Meals · 2024-03-07 | Botox | $23 |
| Axonics | Meals · 2024-03-01 | Axonics | $30 |
| Astellas Pharma US | Meals · 2024-02-21 | Myrbetriq | $19 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $1,005
| Astellas Pharma US | Myrbetriq | $297 | 7 payments
|
| Boston Scientific | Solyx Sis System | $220 | 4 payments
|
| Sumitomo Pharma America | Gemtesa | $140 | 8 payments
|
| Pfizer | Premarin | $134 | 7 payments
|
| Axonics | Axonics | $130 | 3 payments
|
| Caldera Medical | Desara | $58 | 1 payment
|
| AbbVie | Botox | $25 | 1 payment
|
2022: $1,960
| Axonics | Axonics | $1,387 | 13 payments
|
| Pfizer | Premarin | $197 | 10 payments
|
| Boston Scientific | Upsylon | $157 | 6 payments
|
| Urovant Sciences | Gemtesa | $125 | 9 payments
|
| Allergan | Botox | $46 | 2 payments
|
| Astellas Pharma US | Myrbetriq | $33 | 2 payments
|
| TherapeuticsMD | Annovera | $15 | 1 payment
|
2021: $1,449
| Axonics | Axonics R-Snm System | $609 | 6 payments
|
| Allergan | Botox | $285 | 9 payments
|
| Pfizer | Premarin | $218 | 17 payments
|
| Coloplast | Altis | $206 | 3 payments
|
| Astellas Pharma US | Myrbetriq | $46 | 3 payments
|
| Boston Scientific | Upsylon | $34 | 2 payments
|
| TherapeuticsMD | Imvexxy | $20 | 1 payment
|
| Myovant Sciences | Myfembree | $16 | 1 payment
|
| Hologic | Thinprep 2000 Processor | $15 | 1 payment
|
2020: $190
| Axonics Modulation Technologies | Axonics R-Snm System | $101 | 3 payments
|
| Pfizer | Premarin | $43 | 2 payments
|
| Coloplast | Female Incontinence | $20 | 1 payment
|
| Allergan | Botox | $14 | 1 payment
|
| TherapeuticsMD | Annovera | $12 | 1 payment
|
2019: $91
| Medtronic USA | Interstim | $64 | 2 payments
|
| Boston Scientific | General - Female Sui | $27 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 93.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1245573039
- Licence
- CA A131712California A131712: Current · expires 2028-04-30
- Trained
- University of California, San Diego School of Medicine, 2013 · 13 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VF0040X (207VF0040X)
- Mailing address
- 333 City Blvd W Ste 1400, Orange, CA, 92868
- NPI first listed
- 2013-04-01
- NPI last updated
- 2024-10-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 700 Lawrence Expy, Santa Clara, CA, 95051
This office lists an electronic records connection.